Jazz Pharmaceuticals Plc (JAZZ) announced on Tuesday that its Jazz Investments I Ltd. intends to offer $850 million of senior notes due 2030 in a private offering.
Jazz also expects to grant the initial purchasers of the notes an option to purchase up to an additional $150 million of notes.
The drug maker expects to use a portion of the net proceeds to prepay up to around $350 million of the term loans and for general corporate purposes.
Jazz also aims to repurchase up to $150 million of its shares from purchasers of the notes in privately negotiated transactions.
For comments and feedback: editorial@rttnews.com